TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04765774

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music
Description: The music chosen by the patient will be played in the music group.
Study: NCT05477160

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STAR-0215 (SC)
Description: STAR-0215 will be administered as an SC bolus injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STAR-0215 (SC)
Description: STAR-0215 will be administered as an SC bolus injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STAR-0215 (SC)
Description: STAR-0215 will be administered as an SC bolus injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STAR-0215 (SC)
Description: STAR-0215 will be administered as an SC bolus injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (SC)
Description: Placebo will be administered as an SC bolus injection.
Study: NCT04894812

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neurodevelopmental technique
Description: 1. st month: postural maintenance; exercises with weight on forearms and hands, in sitting, crawling, semi-kneeling and standing positions with support from therapist.~2. nd month: balance and corrective reactions; using CP ball and tilt board.~3. rd month: ambulation training; appropriate to motor development level (crawling, creeping, walking in a semi-kneeling position and walking between parallel bars).
Study: NCT04935047

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multilingual Support
Description: Multilingual Support is a classroom intervention, which is designed to be delivered in classes of adult learning of a new language. The intervention involves the use of a language assistant, who is at minimum independent user (B1) in the language to be learned (in this case Norwegian), according to the language proficiency scale of the Common European Framework of Reference (CEFR) for languages, learning, teaching, assessment (Little, 2006). The language assistant will be in the classroom for seven hours a week, collaborating with the teacher in providing language training. In classrooms where participants have different primary languages, the language assistant(s) must cover all languages represented in the classroom.
Study: NCT06081673

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Penpulimab injection
Description: Penpulimab is a human immunoglobulin G1(IgG1) monoclonal antibody (mAb) directly programmed cell death-1 (PD-1). AK105 can effectively prevent human PD-1 binds to programmed cell death-1 ligand 1(PD-L1) and programmed cell death-1 ligand 2(PD-L2)； 200mg,D1, IV(21 days/cycle).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatin
Description: Cisplatin :75mg/m2, D1, IV(21 days/cycle)
Study: NCT05477160

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (SC)
Description: Placebo will be administered as an SC bolus injection.
Study: NCT06081673

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: albumin-paclitaxel
Description: albumin-paclitaxel :260mg/m2,IVgtt,D1(21 days/cycle)
Study: NCT05477160

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (SC)
Description: Placebo will be administered as an SC bolus injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (SC)
Description: Placebo will be administered as an SC bolus injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STAR-0215 (IV)
Description: STAR-0215 will be administered as an IV bolus injection.
Study: NCT05050903

Intervention type: OTHER
Intervention: Rhinovirus infection
Description: Inoculation with rhinovirus-16

Intervention type: OTHER
Intervention: Rhinovirus infection
Description: Inoculation with rhinovirus-16
Study: NCT05044585

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Remote Automated Monitoring System
Description: The subject will be monitored with conventional monitoring devices as well as the MultiSense patch.
Study: NCT05726604

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Respiratory gating
Description: 10 minutes breathing motion monitoring during an additional CT scan to establish a more accurate cardiac and LAD dosimetry compared to reality
Study: NCT05219643

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NAVA
Description: Nava level is set to maintain the target tidal volume: 6-10ml / kg (pbw). The trigger sensitivity is 0.5uv. The expiratory trigger sensitivity: the built-in software of the ventilator is set to 70% of the peak value of diaphragm electrical activity.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PSV
Description: According to the doctor's experience, maintain the target tidal volume: 6-10ml / kg (pbw); trigger sensitivity: 1.5-2l/min, expiratory trigger sensitivity: 30% inspiratory peak flow rate.
Study: NCT05477160

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (IV)
Description: Placebo will be administered as an IV bolus injection.
Study: NCT06088173

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercises
Description: Patients in both group will use Kleinert splint. Sessions will start with ice application if there is edema and continue with scar tissue massage. After general hand massage, passive flexion, active extension exercises; tenodesis exercise and passive punch will be performed for the postoperative (postop) first two weeks. In postop 3-4 weeks, four finger sliding exercises, active half fist and NMES (Neuromuscular electrical stimulation) will be performed. In postop 5-6 weeks, blocking exercises, full punch, grappling hooks and small on-digits holding and releasing exercises will be performed additionally.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercises and Education
Description: In addition to the same treatment as the patients in the first group, in the first postoperative (postop) two weeks, the gmi will be explained to the patients and lateralization will be started. lateralization refers to right-left discrimination and the patients will be presented with visuals with the help of the noi recognise app and they will have to decide whether the visual is right or left hand. In the postop 3-4th weeks, the motor imagery stage will be started and imagery will be practiced with the help of the same app. In postop 5-6 weeks, mirror therapy will be practiced with the help of a mirror box.
Study: NCT05611242

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MT+CAS with IV-AP
Description: Mechanical Thrombectomy is a treatment for stroke that removes clots that block large blood vessels. Carotid stenting is a procedure that is deployed within the lumen of the carotid artery which treats the narrowing of the carotid artery. With added intravenous antiplatelet therapy.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MT+CAS with PO-AP
Description: Mechanical Thrombectomy is a treatment for stroke that removes clots that block large blood vessels. Carotid stenting is a procedure that is deployed within the lumen of the carotid artery which treats the narrowing of the carotid artery. With added oral antiplatelet therapy.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MT+CAT with PO-AP
Description: Mechanical Thrombectomy is a treatment for stroke that removes clots that block large blood vessels. Carotid stenting is a procedure that is deployed within the lumen of the carotid artery which treats the narrowing of the carotid artery. With added oral antiplatelet therapy
Study: NCT06059300

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Digital Breast Tomosynthesis
Description: Screening with Digital Breast Tomosynthesis instead of Digital Mammography, for two screening rounds
Study: NCT06090344

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional video format
Description: 6 x 3 minute videos designed in the same format as traditionally found on the internet

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Evidence-informed video format
Description: 6 x 3 minute videos designed in the format recommended by advice in the literature
Study: NCT06219434

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Relaxation
Description: Participate in mindfulness program

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Functional Magnetic Resonance Imaging
Description: Undergo fMRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study: NCT05356143

Intervention type: DRUG
Group type: OTHER
Intervention: Rupatadine
Description: Oral single dose 10 mg tablet

Intervention type: DRUG
Group type: OTHER
Intervention: Rupatadine
Description: Oral single dose 10 mg tablet
Study: NCT06437600

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Immediate angioplasty
Description: See arm/group descriptions.
Study: NCT05130840

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI
Description: MRI Brain (unless already done as standard of care within 2 months on enrollment to evaluate for CNS disease) MRI Brain at 2 timepoints 6 months apart (+/- 8 weeks).

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI
Description: MRI Brain (unless already done as standard of care within 2 months on enrollment to evaluate for CNS disease) MRI Brain at 2 timepoints 6 months apart (+/- 8 weeks).

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lumbar puncture
Description: LP at 2 timepoints 6 months apart (+/- 8 weeks). LP will be performed to analyze cerebrospinal fluid for: cytology, circulating tumor cells and cell-free DNA.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lumbar puncture
Description: LP at 2 timepoints 6 months apart (+/- 8 weeks). LP will be performed to analyze cerebrospinal fluid for: cytology, circulating tumor cells and cell-free DNA.
Study: NCT06180603

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Gravity fluid drainage in the radiology department
Description: Patients will be referred to the radiology department. Thoracentesis will be performed according to local guidelines.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Manual drainage in the emergency department
Description: Thoracentesis will be performed according to current guidelines in the emergency department. Fluid will manually be drained using a syringe connected to a three-way stopcock. Thoracentesis will be stopped early if:
Study: NCT04779099

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief 4-session intervention for borderline personality disorder
Description: Intervention consists of weekly 50-minute 1:1 sessions focused on psycho-education, here-and-now problem solving and safety planning. One of the sessions can involve a significant other to provide psychoeducation about the disorder and to facilitate support. This intervention is detailed in a published manual.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment as usual
Description: TAU comprises access to psychiatric assessment, medication review, and unscheduled sessions with allied health professionals using a drop-in model of care.
Study: NCT06195501

Intervention type: DIAGNOSTIC_TEST
Intervention: Flexible Endoscopic Evaluation of Swallowing (FEES) ; Transesophageal Ecocardiography (TEE)
Description: Flexible Endoscopic Evaluation of Swallowing (FEES):~FEES is performed for analysis of swallowing ability according to the same methodology as in the initial trial: one day before a TEE and max. 4 hours after TEE. Before the FEES anticongestive nose drops are applied and the nostrils are anaesthetized by applying a lidocaine gel via cotton sticks. During the FEES examination the participants sit upright and are asked to swallow various consistencies: FEES is aborted in case of aspiration of any of the consistencies during the examination.~Transesophageal Ecocardiography (TEE):~For the TEE anesthesia is applied via intravenous injection of propofol or a combined anesthesia, through intravenous application of propofol and local anesthesia, using lidocaine spray. All patients undergoing a TEE are sober before and at least two to four hours after TEE.
Study: NCT05915494

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: intermittent pneumatic compression, physiotherapy, and walking
Description: intermittent pneumatic compression group (n = 20 inhalation injury children). in this children group, intermittent pneumatic compression will be used to resist diaphragm muscle during 10-set-training session which will be done five session per the week, for 12 weeks. besides this training, traditional physical therapy program will be handled). In other inhalation group, n =20, traditional physical therapy program will be handled only). Also, free walking for 30 minutes daily will be performed by children.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: physiotherapy and walking
Description: in this children group, n = 20, for 12 weeks, traditional physical therapy program (chest physical therapy, flexibility exercises, range of motion exercises) will be handled. Also, free walking for 30 minutes daily will be performed by children.
Study: NCT05544734

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydrocodone 5Mg/Acetaminophen 325Mg Tab
Description: 5 mg/325 mg tablet
Study: NCT06006884

Intervention type: PROCEDURE
Intervention: Bronchoscopies and Bronchoalveolar Lavages (BALs)
Description: Bronchoscopies use a thin, lighted tube, which enters through the mouth or nose and moves down the throat to the airways to look at the lungs. BALs are done during bronchoscopies to collect samples from the lungs for testing. During this procedure, a saline solution is put through the tube to wash the airways and collect a fluid sample.

Intervention type: PROCEDURE
Intervention: Bronchoscopies and Bronchoalveolar Lavages (BALs)
Description: Bronchoscopies use a thin, lighted tube, which enters through the mouth or nose and moves down the throat to the airways to look at the lungs. BALs are done during bronchoscopies to collect samples from the lungs for testing. During this procedure, a saline solution is put through the tube to wash the airways and collect a fluid sample.

Intervention type: DIAGNOSTIC_TEST
Intervention: Chest Tomography (CT)
Description: X-ray to create images of the bones and internal organs of the body

Intervention type: DIAGNOSTIC_TEST
Intervention: Chest Tomography (CT)
Description: X-ray to create images of the bones and internal organs of the body

Intervention type: DIAGNOSTIC_TEST
Intervention: Electrocardiogram (ECG)
Description: Measures the electrical activity of the heart by using sticky pads that are placed on your chest and limbs.

Intervention type: DIAGNOSTIC_TEST
Intervention: Electrocardiogram (ECG)
Description: Measures the electrical activity of the heart by using sticky pads that are placed on your chest and limbs.

Intervention type: DIAGNOSTIC_TEST
Intervention: Pulmonary function tests (PFTs)
Description: Testing to measure how well lungs are working

Intervention type: DIAGNOSTIC_TEST
Intervention: Pulmonary function tests (PFTs)
Description: Testing to measure how well lungs are working

Intervention type: DIAGNOSTIC_TEST
Intervention: 6 minute walk test (6MWT)
Description: Walking test to see how well the lungs function with exercise over 6 minutes

Intervention type: DIAGNOSTIC_TEST
Intervention: 6 minute walk test (6MWT)
Description: Walking test to see how well the lungs function with exercise over 6 minutes
Study: NCT05636332

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: 12 lead Electrocardiogram
Description: 12 lead Electrocardiogram

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: 12 lead Electrocardiogram
Description: 12 lead Electrocardiogram

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: 12 lead Electrocardiogram
Description: 12 lead Electrocardiogram
Study: NCT05961462

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exercise training
Description: Patients randomized to the exercise group will be offered aerobic exercise plan containing 12 sessions over 4 weeks (3 times per week).
Study: NCT06524973

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemedicine
Description: Attend telehealth self-management coaching sessions
Study: NCT05356143

Intervention type: DRUG
Group type: OTHER
Intervention: Rupatadine
Description: Oral single dose 10 mg tablet
Study: NCT05683327

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: UltraHA® 75 mg/capsule
Description: Take 2 capsules per day at any time.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: UltraHA® 40 mg/capsule
Description: Take 2 capsules per day at any time.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Take 2 capsules per day at any time.
Study: NCT06437106

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: A blanket impregnated with the mother's odor
Description: Intervention group 1 consists of premature babies who receive a blanket impregnated with the mother's odor.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: blanket without mother's smell
Description: Intervention group two consists of preterm infants who receive blanket without mother's odor.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: control group
Description: The control group includes premature babies who are not subjected to any intervention and receive the usual care.
Study: NCT04948229

Intervention type: OTHER
Intervention: Blood serum samples
Description: Blood serum samples will be taken.

Intervention type: OTHER
Intervention: Blood serum samples
Description: Blood serum samples will be taken.

Intervention type: OTHER
Intervention: Blood serum samples
Description: Blood serum samples will be taken.
Study: NCT05089695

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Noninvasive respiratory support
Description: Treatment of acute hypoxemic respiratory failure
Study: NCT04779099

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: TAU comprises access to psychiatric assessment, medication review, and unscheduled sessions with allied health professionals using a drop-in model of care.
Study: NCT05862688

Intervention type: OTHER
Intervention: antimicrobial therapy
Description: antimicrobial therapy
Study: NCT05089695

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Noninvasive respiratory support
Description: Treatment of acute hypoxemic respiratory failure

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Noninvasive respiratory support
Description: Treatment of acute hypoxemic respiratory failure
Study: NCT05958758

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin-assisted therapy within a community of practice model (group administered)
Description: The community of practice is 10 weeks long, meeting virtually for 2 hours each week, in a structured process, run through the Roots to Thrive treatment program. The psilocybin-assited therapy sessions occur midway through the 10-week program.
Study: NCT06118567

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nitrous oxide
Description: Nitrous oxide gas.
Study: NCT05544734

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen 1000mg
Description: 1000 mg tablet

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen 1000mg
Description: 1000 mg tablet
Study: NCT06118567

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Room Air
Description: Room Air
Study: NCT04846348

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Topical preparation of sodium cromolyn 5%, diphenhydramine 1% and trolamine salicylate 10% in emollient cream base.
Description: Combination of ingredients includes 2 agents which target mast cell mediators and one agent which globally reduces mast cell degranulation combined in an emollient cream base (Vanicream).components: Vanicream: Over the counter emollient cream Diphenhydramine Antihistamine Trolamine salicylate Prostaglandin inhibitor, antiinflammatory Cromolyn Sodium Mast cell degranulation inhibitor
Study: NCT05544734

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen 400 mg
Description: 400 mg tablet
Study: NCT06524973

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Counseling
Description: Attend telehealth self-management coaching sessions

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive standard of care

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inrweview
Description: Ancillary studies
Study: NCT05685030

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: product vehicle (sunflower oil)

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Limosilactobacillus reuteri CCT 7862
Description: Limosilactobacillus reuteri CCT 7862 - 1 x 10e9 UFC/ day.
Study: NCT05685030

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis CCT 7858 + Lactobacillus rhamnosus CCT 7863
Description: Bifidobacterium lactis CCT 7858 + Lactobacillus rhamnosus CCT 7863 - 1 x 10e9 UFC/ day
Study: NCT05640869

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Modified Diabetes Prevention Program Curriculum
Description: The modified DPP curriculum will be an exact copy of the current DPP curriculum except that references to the prevention of diabetes will be modified to prevention of health outcomes associated with overweight/obesity and/or management of overweight/obesity.
Study: NCT05340114

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CEREBO®
Description: Near-infrared based point-of-care portable intracranial hematoma detector
Study: NCT05623163

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EndoZip System
Description: The Nitinotes EndoZip system is designed to allow for the creation of multiple internal gastric segmentation (up to 5 sutures) in the stomach by using an endoscopic approach. The system allows the forming of wall-to-wall longitudinal attachments of the anterior and posterior stomach walls, creating multiple strictures within.~Creation of this segmentation may significantly reduce gastric volume, may affect gastric motility and consequently, reduce weight.
Study: NCT06551909

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Neoaddjuvant Stereotactic Radiotherapy with Simultaneous Integrated Boost
Description: Patients with Glioblastoma will receive neoadjuvant stereotactic radiotherapy to Planning Target Volume (PTV) to 30 Gy in 5 fractions, and a Simultaneous Integrated Boost delivering 35-50 GY to GTV. Patients will be divided into groups of 5 and will receive (in the absence of 2 G4 toxicities per group), the following dose levels: 35-40-42.5-45-47.5 and 50 Gy. Standard Temozolomide chemotherapy will be prescribed after surgery.